Bortezomib in combination with thalidomide-dexamethasone for previously untreated multiple myeloma
Author:
Affiliation:
1. Department of Lymphoma/MyelomaThe University of Texas M. D. Anderson Cancer Center, Houston, TX, USA
Publisher
Informa UK Limited
Subject
Hematology,Hematology
Link
https://www.tandfonline.com/doi/pdf/10.1080/10245330701214236
Reference29 articles.
1. Thalidomide and dexamethasone combination for refractory multiple myeloma
2. Thalidomide and dexamethasone for resistant multiple myeloma
3. Combination Therapy With Thalidomide Plus Dexamethasone for Newly Diagnosed Myeloma
4. Thalidomide Alone or With Dexamethasone for Previously Untreated Multiple Myeloma
5. A Phase 2 Study of Bortezomib in Relapsed, Refractory Myeloma
Cited by 102 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Potential Use of Thalidomide in Glioblastoma Treatment: An Updated Brief Overview;Metabolites;2023-04-11
2. Myeloma and Leukemia;Oncologic Imaging : a Multidisciplinary Approach;2023
3. Adding bendamustine to melphalan before ASCT improves CR rate in myeloma vs. melphalan alone: A randomized phase-2 trial;Bone Marrow Transplantation;2022-04-20
4. Thromboembolic events and thromboprophylaxis associated with immunomodulators in multiple myeloma patients: a real-life study;Journal of Cancer Research and Clinical Oncology;2021-06-18
5. Prognostic impact of early‐versus‐late responses to different induction regimens in patients with myeloma undergoing autologous hematopoietic cell transplantation: Results from the CALM study by the CMWP of the EBMT;European Journal of Haematology;2021-02-27
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3